The Lyme Disease IgG Antibody Immunoblot Test confirms exposure to Borrelia burgdorferi, the bacteria that cause Lyme disease. It detects IgG antibodies, which usually appear weeks after infection and remain present for months to years. Doctors use this test to confirm a positive screening result, evaluate late-stage Lyme symptoms, and support diagnosis in patients with joint pain, fatigue, or neurological complications from suspected Lyme disease.

The Lyme Disease IgG IgM Antibodies Immunoblot Test detects antibodies to Borrelia burgdorferi, the bacteria causing Lyme disease. IgM indicates recent infection, while IgG suggests past or ongoing infection. Doctors order this test to confirm exposure after ELISA screening or when symptoms such as rash, fatigue, joint pain, or neurological issues appear. Results provide critical insight for diagnosing and managing Lyme disease with greater accuracy.

The Lyme Disease Antibody Test with Reflex to Blot IgG IgM screens for antibodies to Borrelia burgdorferi, the bacteria that cause Lyme disease. If results are positive or equivocal, a Western blot IgG/IgM is reflexively performed for confirmation. Doctors order this test for patients with tick exposure, rash, joint pain, or neurological symptoms. Results help confirm infection, guide treatment decisions, and support early detection to prevent complications.

The Lyme Disease DNA Qualitative Blood Test detects genetic material from Borrelia burgdorferi, the bacteria that cause Lyme disease. This test identifies active infection by analyzing bacterial DNA in the blood. Doctors use it to confirm Lyme disease in patients with symptoms such as fever, fatigue, or joint pain, particularly after tick exposure. It supports early diagnosis and guides treatment to prevent long-term complications.

The Ehrlichia chaffeensis IgG IgM Antibodies Test detects immune response to the bacterium responsible for human monocytic ehrlichiosis (HME). Measuring both IgM and IgG provides information on recent or past infection, helping identify acute illness or prior exposure. This blood test supports evaluation of tick-borne disease in patients with symptoms such as fever, fatigue, or cytopenias, guiding clinical assessment and patient management.